Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune Response Kinetics of Prevenar-13 vs Pneumovax-II in Healthy Adults
NCT01432158Phase 3Completed
- Sponsor
- University of Oxford
- Start
- Jan 2012
- Primary completion
- Aug 2012
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of pneumococcal 13-valent conjugate vaccine in pneumococcal disease, sponsored by University of Oxford. Started Jan 2012; status: completed.
02
Drugs
pneumococcal 13-valent conjugate vaccine
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on NCT01432158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01432158.